Skip to main content
ALK-Abelló logo

ALK-Abelló — Investor Relations & Filings

Ticker · ALK ISIN · DK0061802139 LEI · 529900SGCREUZCZ7P020 CO Manufacturing
Open in API
Filings indexed 1,210 across all filing types
Latest filing 2021-05-10 Director's Dealing
Country DK Denmark
Listing CO ALK

About ALK-Abelló

https://www.alk.net

ALK-Abelló is a global, research-driven pharmaceutical company specializing in the prevention, diagnosis, and treatment of allergies. The company is a world leader in allergy immunotherapy (AIT), also known as allergy vaccination, which is a disease-modifying treatment that targets the underlying cause of the allergy rather than just the symptoms. Its portfolio includes a range of allergy treatments and services, with products such as injections, sublingual tablets, and emergency treatments for severe allergic reactions like anaphylaxis. With over a century of experience, ALK-Abelló focuses on developing pharmaceutical products to improve the quality of life for people with allergies globally.

Recent filings

Filing Released Lang Actions
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
Director's Dealing Classification · 100% confidence The document is a short announcement regarding the reporting of transactions by company management (insiders) in ALK-Abelló A/S shares. It explicitly references EU Market Abuse Regulation (MAR) Article 19, which governs director/insider dealing disclosures. Since the document is a brief notification pointing to an attached file containing the actual transaction details, it falls under the category of Director's Dealing (DIRS).
2021-05-10 Danish
Director's Dealing 2021
Director's Dealing Classification · 98% confidence The document explicitly states it is a 'Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff' and references Article 19 of the Market Abuse Regulation (MAR), which mandates reporting of transactions by persons discharging managerial responsibilities (PDMRs). This directly corresponds to insider trading or director's dealing reports. The filing type 'DIRS' (Director's Dealing) is the most appropriate classification for reports detailing personal share transactions by company directors and executives.
2021-05-10 English
Director's Dealing 2021
Director's Dealing Classification · 99% confidence The document text explicitly details 'Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff'. It lists specific transactions (Purchase, Sale) involving shares by individuals identified as 'Member of the Board of Directors' or 'Member of Board of Management' (Jakob Riis, Henrik Jacobi). This content directly corresponds to the reporting of personal share transactions by company directors and executives, which is classified as Director's Dealing.
2021-05-10 English
Grant of share options and performance shares to members of the Board of Management and key employees
Remuneration Information Classification · 95% confidence The document is a corporate announcement (Selskabsmeddelelse) regarding the allocation of stock options and performance shares to the company's management and key employees. This type of disclosure relates to executive compensation and incentive programs. While it involves directors and management, it is specifically about the remuneration structure rather than a change in board composition (MANG) or a personal trade (DIRS). Given the focus on the remuneration policy and the specific details of the incentive schemes, it falls under the category of Remuneration Information.
2021-03-26 Danish
Grant of share options and performance shares to members of the Board of Management and key employees
Remuneration Information Classification · 95% confidence The document is a company release detailing the grant of share options and performance shares to the Board of Management and key employees. This information pertains to executive compensation and remuneration policies, which aligns with the definition for 'Remuneration Information' (DEF 14A). While it mentions the AGM, it is not an AGM report, but rather a specific disclosure regarding incentive plans.
2021-03-26 English
Remuneration Information 2021
Remuneration Information Classification · 99% confidence The document explicitly details the granting of share options and performance shares to the Board of Management and key employees, referencing the company's remuneration policy adopted at the AGM. This content directly relates to executive and employee compensation structures, which falls under Remuneration Information. Although it discusses management, the core subject is the compensation plan itself, not general management changes (MANG) or general governance rules (CGR). The closest fit among the provided definitions is 'Remuneration Information' (DEF 14A), which covers compensation for top executives and directors. The document is a detailed announcement, not a short notice of publication, so RPA/RNS is less appropriate than the specific content category.
2021-03-26 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.